1. Home
  2. TRVG vs EOLS Comparison

TRVG vs EOLS Comparison

Compare TRVG & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo trivago N.V.

TRVG

trivago N.V.

HOLD

Current Price

$2.83

Market Cap

278.1M

Sector

Technology

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$4.42

Market Cap

304.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRVG
EOLS
Founded
2005
2012
Country
Germany
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
278.1M
304.0M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
TRVG
EOLS
Price
$2.83
$4.42
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$4.09
$17.40
AVG Volume (30 Days)
60.3K
1.5M
Earning Date
02-03-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.18
N/A
Revenue
$644,489,844.00
$285,823,000.00
Revenue This Year
$18.54
$13.70
Revenue Next Year
$9.07
$13.40
P/E Ratio
$15.90
N/A
Revenue Growth
19.11
15.10
52 Week Low
$2.71
$4.41
52 Week High
$5.83
$17.12

Technical Indicators

Market Signals
Indicator
TRVG
EOLS
Relative Strength Index (RSI) 46.55 28.48
Support Level $2.75 $4.56
Resistance Level $3.16 $4.99
Average True Range (ATR) 0.11 0.26
MACD 0.01 0.01
Stochastic Oscillator 20.71 2.40

Price Performance

Historical Comparison
TRVG
EOLS

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. Its geographic areas are the United States, Germany, the United Kingdom, Canada, Japan, and All other countries.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: